Finance Home - My Yahoo - Yahoo! - Help

Tuesday, December 8, 2009, 9:27PM ET - U.S. Markets Closed. Dow  1.00% Nasdaq  0.76%

Molecular Insight Pharmaceuticals, Inc. (MIPI)

At 4:00PM ET: 2.54   0.48 (15.89%)

MORE ON MIPI

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Thu, Dec 3, 2009 • MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibi EDGAR Online (Thu, Dec 3) Tue, Nov 24, 2009 • MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD EDGAR Online (Tue, Nov 24) • Molecular Insight Pharmaceuticals Announces Changes to Board Marketwire (Tue, Nov 24) Fri, Nov 13, 2009 • MOLECULAR INSIGHT PHARMACEUTICALS, INC. Financials EDGAR Online Financials (Fri, Nov 13) Wed, Nov 11, 2009 • Molecular Insight Pharmaceuticals to Present at Lazard Capital Markets Annual Healthcare Conference Marketwire (Wed, Nov 11) Mon, Nov 9, 2009 • Molecular Insight Pharmaceuticals, Inc Earnings Call scheduled for 4:30 pm ET today CCBN (Mon, Nov 9) • MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Even EDGAR Online (Mon, Nov 9) • Molecular Insight Pharmaceuticals Reports Third Quarter 2009 Financial Results Marketwire (Mon, Nov 9) • Q3 2009 Molecular Insight Pharmaceuticals, Inc Earnings Release - Time Not Supplied CCBN (Mon, Nov 9) • MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online (Mon, Nov 9) Mon, Oct 26, 2009 • Molecular Insight Pharmaceuticals, Inc. to Report Third Quarter Financial Results on November 9, 2009 Marketwire (Mon, Oct 26) Fri, Oct 23, 2009 • Molecular Insight inks Onalta deals abroad at bizjournals.com (Fri, Oct 23) Wed, Oct 21, 2009 • Molecular Insight Pharmaceuticals Finalizes Onalta(TM) Manufacturing and Supply Agreements Marketwire (Wed, Oct 21) Thu, Oct 15, 2009 • Venture Capitalists Resist Regulatory Calls at TheStreet.com (Thu, Oct 15) • Coverage initiated on Molecular Insight Pharma by Brean Murray Briefing.com (Thu, Oct 15) Mon, Oct 5, 2009 • Molecular Insight Pharmaceuticals Presents Azedra(TM) 12-Month Efficacy Data From Phase I Clinical Trial in Neuroendocrine Tumors Marketwire (Mon, Oct 5) Fri, Sep 4, 2009 • MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Sta EDGAR Online (Fri, Sep 4) • Molecular Insight Pharmaceuticals, Inc. to Present at Rodman and Renshaw 11th Annual Healthcare Conference Marketwire (Fri, Sep 4) Wed, Sep 2, 2009 • MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD EDGAR Online (Wed, Sep 2) • Molecular Insight Pharmaceuticals, Inc. Sub-Licenses Onalta(TM) for Development Marketwire (Wed, Sep 2) Older Headlines - Download Recent Headlines View headlines from: Wed, Sep 2, 2009Wed, Aug 26, 2009Wed, Aug 19, 2009Wed, Aug 12, 2009Wed, Aug 5, 2009Wed, Jul 29, 2009Wed, Jul 22, 2009Wed, Jul 15, 2009Wed, Jul 8, 2009Wed, Jul 1, 2009 Add MIPI News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage